<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "epoprostenol (CARIPUL) inj VIAL">
<dose><value>2</value>
<value>3</value>
<value>4</value>
<value>5</value>
<value>6</value>
<value>7</value>
<value>8</value>
<value>9</value>
<value>10</value>
<value>11</value>
<value>12</value>
<value>13</value>
<value>14</value>
<value>15</value>
<value>16</value>
<value>17</value>
<value>18</value>
<value>19</value>
<value>20</value>
</dose>
<route><value>IV</value>
</route>
<strength><value>0.5 mg</value>
<value>1.5 mg</value>
</strength>
<frequency><value>CONTINUOUS</value>
</frequency>
<instruction><value>Administer as continuous infusion.  Adjust infusion by 1 to 2 ng/kg/minute every 15 minutes to allow assessment of clinical response/tolerability/adverse effects. (1 mcg = 1000 ng)</value>
</instruction>
<volume></volume>
<units><value>ng/kg/minute</value>
</units>
<Population></Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes></AdditionalNotes>
<BackgroundInformation><value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6861</value>
<value>http://intraweb01.albertahealthservices.ca/Pharmacy/AHS_FORMULARY/search_details.aspx?id=6862</value>
</BackgroundInformation>
<PRNInformation></PRNInformation>
<AHSFormularyStatus><value>Formulary with Restrictions.</value>
</AHSFormularyStatus>
<AHFSName><value>Vasodilating Agents</value>
</AHFSName>
<HighAlert><value>YES</value>
</HighAlert>
</drug>